BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30683264)

  • 1. Cancer Screening and Prevention Highlights in Gynecologic Cancer.
    Staples JN; Duska LR
    Obstet Gynecol Clin North Am; 2019 Mar; 46(1):19-36. PubMed ID: 30683264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's knowledge of Pap smear test and human papillomavirus: acceptance of HPV vaccination to themselves and their daughters in an Islamic society.
    Ilter E; Celik A; Haliloglu B; Unlugedik E; Midi A; Gunduz T; Ozekici U
    Int J Gynecol Cancer; 2010 Aug; 20(6):1058-62. PubMed ID: 20683417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's knowledge and utilization of gynecological cancer prevention services in the Northwest of Greece.
    Tsakiroglou M; Bakalis M; Valasoulis G; Paschopoulos M; Koliopoulos G; Paraskevaidis E
    Eur J Gynaecol Oncol; 2011; 32(2):178-81. PubMed ID: 21614908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus-related content in state and tribal comprehensive cancer control plans.
    Steele CB; Thomas CN; Richardson LC
    J Womens Health (Larchmt); 2008; 17(1):5-10. PubMed ID: 18240976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quadrivalent papillomavirus vaccine in women over age 26. Cervical screening must remain a priority.
    Prescrire Int; 2011 May; 20(116):121. PubMed ID: 21648175
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
    Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
    J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HPV vaccination and screening to eliminate cervical cancer. FIGO report].
    Ginekol Pol; 2008 Jun; 79(6):445-6. PubMed ID: 18652135
    [No Abstract]   [Full Text] [Related]  

  • 8. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
    Guo F; Hirth JM; Berenson AB
    J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
    Touch S; Oh JK
    BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update of HPV-associated female genital cancers in the United States, 1999-2004.
    Watson M; Saraiya M; Wu X
    J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
    Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
    Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of malignant tumors caused by human papilloma virus (HPV) by vaccination and with the methods of classical gynecologic diagnostics].
    Berencsi G; Sziller I; Melles M
    Orv Hetil; 2006 Aug; 147(31):1449-53. PubMed ID: 16981417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change.
    Franco EL; Mahmud SM; Tota J; Ferenczy A; Coutlée F
    Arch Med Res; 2009 Aug; 40(6):478-85. PubMed ID: 19853188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Providers' practice, recommendations and beliefs about HPV vaccination and their adherence to guidelines about the use of HPV testing, 2007 to 2010.
    Berkowitz Z; Nair N; Saraiya M
    Prev Med; 2016 Jun; 87():128-131. PubMed ID: 26921654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.
    Malo TL; Perkins RB; Lee JH; Vadaparampil ST
    Sex Transm Dis; 2016 Jul; 43(7):438-44. PubMed ID: 27322046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic HPV vaccines: current knowledge of impact on gynecologic premalignancies.
    Harper DM; Williams KB
    Discov Med; 2010 Jul; 10(50):7-17. PubMed ID: 20670593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer: screening and prevention.
    Behtash N; Mehrdad N
    Asian Pac J Cancer Prev; 2006; 7(4):683-6. PubMed ID: 17250453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS).
    Eltoum IA; Roberson J
    Cancer; 2007 Feb; 111(1):34-40. PubMed ID: 17262799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What does HPV vaccination mean for gynecologic cancer screening?].
    Petry KU
    Hautarzt; 2007 Jun; 58(6):501-6. PubMed ID: 17497103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.